Detalles de la búsqueda
1.
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.
Breast Cancer Res Treat
; 205(2): 287-302, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381274
2.
The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry.
Int J Cancer
; 150(1): 124-131, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34460112
3.
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.
Breast Cancer Res Treat
; 194(1): 159-170, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35507134
4.
Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.
Breast Cancer Res Treat
; 188(2): 571-581, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743103
5.
Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands.
Value Health
; 24(5): 668-675, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933235
6.
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
Breast Cancer Res Treat
; 180(3): 675-685, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32124136
7.
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
Breast Cancer Res Treat
; 181(1): 77-86, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236826
8.
An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry.
Acta Oncol
; 59(9): 1123-1130, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32544366
9.
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry.
Qual Life Res
; 29(12): 3363-3374, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816222
10.
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.
Int J Cancer
; 145(5): 1325-1333, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30748011
11.
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
Int J Cancer
; 145(1): 274-283, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30588619
12.
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.
Lancet Oncol
; 18(11): 1502-1511, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29031778
13.
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients.
Breast Cancer Res Treat
; 163(1): 83-91, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28205044
14.
Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.
Oncology
; 93(5): 323-328, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28848182
15.
Hybrid 18F-FDG PET/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy.
Eur J Nucl Med Mol Imaging
; 44(11): 1796-1805, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28600647
16.
Caregiving demands and caregivers' psychological outcomes: the mediating role of perceived injustice.
Clin Rehabil
; 31(3): 403-413, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27127200
17.
Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium.
Oncologist
; 21(5): 555-62, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27009939
18.
Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study.
Breast Cancer Res Treat
; 156(3): 465-472, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27013474
19.
Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium.
Oncologist
; 20(8): 856-63, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099745
20.
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
Breast Cancer Res Treat
; 141(3): 507-14, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24104881